{"cluster": 49, "subcluster": 2, "abstract_summ": "These include severe acute respiratory syndrome coronavirus (SARS\u2010CoV), followed by the Middle East respiratory syndrome coronavirus (MERS\u2010CoV), and recently the SARS\u2010CoV\u20102 coronavirus outbreak which emerged in Wuhan, China, in December 2019.From the beginning of 2002 and 2012, severe respiratory syndrome coronavirus (SARS\u2010CoV) and Middle East respiratory syndrome coronavirus (MERS\u2010CoV) crossed the species barriers to infect humans, causing thousands of infections and hundreds of deaths, respectively.SARS\u2010CoV\u20102 is a novel coronavirus that causes the acute respiratory disease\u2014Coronavirus disease 2019 (COVID\u201019)\u2014which has led to a global health crisis.Basic Protocol: SARS\u2010CoV\u20102 plaque assay using a solid double overlay method Alternate Protocol: SARS\u2010CoV\u20102 plaque assay using a liquid overlay and fixation\u2010staining methodSince the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) infection in humans in late 2019, it has rapidly spread worldwide.Following the severe acute respiratory syndrome coronavirus (SARS\u2010CoV) and Middle East respiratory syndrome coronavirus (MERS\u2010CoV), another highly pathogenic coronavirus named SARS\u2010CoV\u20102 (previously known as 2019\u2010nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world.", "title_summ": "Practical Guidelines for Collection, Manipulation and Inactivation of SARS\u2010CoV\u20102 and COVID\u201019 Clinical SpecimensCOVID\u201019 breakthroughs: separating fact from fictionThe emergence of a novel coronavirus (SARS\u2010CoV\u20102) disease and their neuroinvasive propensity may affect in COVID\u201019 patientsA Guide to COVID\u201019: a global pandemic caused by the novel coronavirus SARS\u2010CoV\u20102Coinfection with COVID\u201019 and Coronavirus HKU1 \u2013 the critical need for repeat testing if clinically indicatedNovel coronavirus disease 2019 (COVID\u201019) and neurodegenerative disordersAge\u2010related rhesus macaque models of COVID\u201019Rationale for targeting Complement in COVID\u201019SARS\u2010CoV\u20102 spike glycoprotein\u2010binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infectionComposition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS\u2010CoV\u20102The neuroinvasive potential of SARS\u2010CoV2 may play a role in the respiratory failure of COVID\u201019 patientsSARS\u2010CoV\u20102 coinfections: Could influenza and the common cold be beneficial?Animal models of mechanisms of SARS\u2010CoV\u20102 infection and COVID\u201019 pathologyThe Importance Of Naturally Attenuated Sars\u2010Cov\u20102In The Fight Against Covid\u201019Prevention and treatment of COVID\u201019 disease by controlled modulation of innate immunityTwo Detailed Plaque Assay Protocols for the Quantification of Infectious SARS\u2010CoV\u20102Evaluate severe acute respiratory syndrome coronavirus 2 infectivity by pseudoviral particlesDoes SARS\u2010Cov\u20102 invade the brain?A short history of COVID\u201019 and other coronavirus\u2010related epidemicsA global treatments for coronaviruses including COVID\u201019SARS\u2010CoV\u20102 infection\u2010induced immune responses: friends or foes?Translational lessons from animal modelsHow did we get here?", "title_abstract_phrases": "These include severe acute respiratory syndrome coronavirus (SARS\u2010CoV), followed by the Middle East respiratory syndrome coronavirus (MERS\u2010CoV), and recently the SARS\u2010CoV\u20102 coronavirus outbreak which emerged in Wuhan, China, in December 2019.The neuroinvasive potential of SARS\u2010CoV2 may play a role in the respiratory failure of COVID\u201019 patientsFollowing the severe acute respiratory syndrome coronavirus (SARS\u2010CoV) and Middle East respiratory syndrome coronavirus (MERS\u2010CoV), another highly pathogenic coronavirus named SARS\u2010CoV\u20102 (previously known as 2019\u2010nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world.Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS\u2010CoV\u20102From the beginning of 2002 and 2012, severe respiratory syndrome coronavirus (SARS\u2010CoV) and Middle East respiratory syndrome coronavirus (MERS\u2010CoV) crossed the species barriers to infect humans, causing thousands of infections and hundreds of deaths, respectively.Prevention and treatment of COVID\u201019 disease by controlled modulation of innate immunityThe recent outbreak of coronavirus disease 2019 (COVID\u201019), triggered by the severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) poses an enormous threat to global public health and economies.We use a mathematical model of viral coinfection to study SARS\u2010CoV\u20102 coinfections, finding that SARS\u2010CoV\u20102 replication is easily suppressed by many common respiratory viruses."}